OTHER EXPENSE, NET - Schedule of Other Expense Net (Details) - USD ($) $ in Millions |
3 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Other Income and Expenses [Abstract] | ||||
| Infineum termination fee, net | $ 0.0 | $ 0.0 | $ (10.9) | |
| Patent infringement settlement gain, net | $ (20.0) | 0.0 | (20.0) | 0.0 |
| Loss on foreign currency remeasurement | 7.1 | 7.7 | 5.7 | |
| Loss on extinguishment of debt and modification | 3.2 | 14.3 | 29.9 | |
| Other, net | (0.9) | 2.0 | 0.7 | |
| Other expense, net | $ 9.4 | $ 4.0 | $ 25.4 | |
| X | ||||||||||
- Definition Gain (Loss) On Extinguishment Of Debt And Modification No definition available.
|
| X | ||||||||||
- Definition Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of gain from litigation settlement for amount awarded from other party. Excludes claims within an insurance entity's normal claims settlement process. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of expense related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of other expense (income) that is infrequent in occurrence or unusual in nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|